Title Sponsors
 

Schwabe, Williamson & Wyatt

 

Jones_Roth_Small.jpg

 

Formal_Cascades_OSU_V_rev-orange.png 

Site Design By

Launch Stage Companies 2012

Investor Group deliberations.jpgFor two months, a core group of investors in the Bend Venture Conference (BVC) has met, challenged and vetted 50 Launch Stage applicants. That total field of submissions was successively narrowed to the top six startups.  Announced at the conclusion of the conference on October 19, 2012, one finalist will earn an investment prize expected to meet or exceed the $250K investment generated last year.

The bulk of the investment is generated from local investors; however, several investors come from Portland, Seattle, the Bay Area, and other states.  For the first time ever, the Oregon Community Foundation (OCF) has made a $25,000 matching investment and, for the second year, the Oregon Growth Account (OGA) will invest up to $50,000.  $200,000 from private investors is required to get the full investment match from OGF and OFA.In alphabetical order, BVC's six Launch Stage finalists are:

  • DesignMedix (Lynn Stevenson, Biotechnology, Portland)  DesignMedix, Inc. develops drugs to overcome drug resistance in multiple diseases, and has a malaria drug nearly ready for human trials.

  • Element 1 Corp (Robert Schluter, Clean Technology, Bend) Element 1 intends to be the dominant global supplier of hydrogen generators to fuel-cell system integrators and other merchant hydrogen applications.

  • Intelligent Power (Ed Davis, Clean Technology, Wilsonville) Intelligent Power provides energy management and control that saves supermarkets 10% on their energy bills, increasing their profits 15%.

  • JettStream (Sarah Cota, Medical Devices &  Equipment, Bend) JettStream is a superior treatment delivery system for children with asthma.

  • RallyCause (Robert Aiello, Internet/Web Services, Bend)  Kickstarter meets Yelp.  Supporters raise money for their chosen cause every time they shop at participating local businesses.

  • Sonivate Medical (David Starr, Medical Devices & Equipment, Beaverton) Sonivate has a disruptive, proprietary, FDA-cleared, medical imaging technology that addresses critical needs in the $5B ultrasound market.

 10/10/12